People
Danforth Advisors, LLC today announced additional regional leadership and support with the appointment of Robert Dickey IV as Managing Director, Mid Atlantic Region.
IDBS, a leader in enterprise scientific informatics platforms, today announced that Christian Marcazzo has joined the company as Vice President and General Manager, effective immediately.
DefiniGEN today announces the appointment of Professor Sir John Savill as a Non-Executive Director of the Board.
Macrophage Pharma Limited announced today the formation of an international Scientific Advisory Board (SAB).
EpicGenetics and Massachusetts General Hospital (MGH) are launching a Phase II clinical trial to test a tuberculosis vaccine, BCG, as a potential treatment for fibromyalgia.
José Baselga, chief medical officer at Memorial Sloan Kettering Cancer Center came under fire this weekend for his failure to disclose financial ties to various pharmaceutical companies when he published research papers in peer-reviewed journals.
The opposition to Takeda Pharmaceutical acquiring Shire has taken on another dimension with a prominent member of the family that created the Japanese pharmaceutical company speaking publicly against the deal.
Dr Wan Yue joins international CIFAR research programme.
National Institute for Innovation in Manufacturing Biopharmaceuticals Funds UMB Researcher
In testimony before the U.S. House Energy and Commerce Subcommittee on Health today, pharmacist-owner Hugh M. Chancy urged support for draft legislation to prohibit restrictive contractual language, often referred to as “gag clauses,” that may result in patients being charged inflated prices for their medications.
PRESS RELEASES